Clinical Trials Directory

Trials / Completed

CompletedNCT04219592

IgG-4 Levels in Systemic Sclerosis

Comparing IgG-4 Levels in Systemic Sclerosis Patients vs. Healthy Controls

Status
Completed
Phase
Study type
Observational
Enrollment
154 (actual)
Sponsor
Meir Medical Center · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Accepted

Summary

This is an observational - non interventional study. The investigators will compare IgG4 levels of 80 healthy donors (from Israel blood bank - MDA) and 80 Systemic Sclerosis patients from Meir Medical Center.

Detailed description

IgG4 levels will be obtained from medical records of 80 SSc patients between the years 2000-2019. These will be compared to IgG4 levels from sera of 80 healthy donors (from Israel blood-bank - MDA). Correlations between IgG4 levels and the following will be made: age, sex, disease type (limited or diffused SSc), disease duration, medications.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTIgG4 measurement (non-interventional, just obtaining data from medical records)IgG4 measurement in mg/dL

Timeline

Start date
2019-05-30
Primary completion
2024-09-30
Completion
2024-10-30
First posted
2020-01-07
Last updated
2025-05-16

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT04219592. Inclusion in this directory is not an endorsement.

IgG-4 Levels in Systemic Sclerosis (NCT04219592) · Clinical Trials Directory